NCT06862544Active, not recruiting
Migraine Research with Smartwatch Application
Migraine Research with Smartwatch Application (MIRA) - a Prospective Migraine Study with Wearables
Source: ClinicalTrials.gov · Last updated 14 Mar 2025
Brief summary (registry, in English)
This clinical, prospective study aims to evaluate the effectiveness of wearable technology in capturing real-time data to assess disease activity in patients with episodic or chronic migraine undergoing different therapy strategies, including botulinum toxin, prophylactic, and acute treatments. Participants will also document migraine attacks, triggers, and symptoms through a digital migraine diary app. By combining continuous smartwatch data, the migraine diary and the implementation of questionnaires, the study seeks to provide a comprehensive understanding of how migraines and their treatments impact daily life and patient outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 55 (actual)
- First submitted
- 2 Mar 2025
- Start date
- 17 May 2024
- Primary completion date
- 7 Mar 2025
- Lead sponsor
- Heinrich-Heine University, Duesseldorf
- Diseases
- Migraine
- NCT number
- NCT06862544
What you commit to
- Study type: Observational
- Participants enrolled: 55
- From 17 May 2024 to the primary completion date, 7 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Comorbidity leading to impaired comprehension or successful completion of the study, such as (but not limited to) psychiatric comorbidities or dementia. The decision will be at the discretion of the investigators.
Other
- Missing informed consent
- Unwillingness or inability to use the smartphone app
Who the study is looking for
- Patients must meet the following criteria to be eligible to participate in the study:
- ≥ 18 years of age
- Diagnosed migraine syndrome
- Possession and ability to use a smartphone (Android 8.1 or later, or iOS 12.3 or later)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical Faculty, Heinrich-Heine-University Coordinator of this site? Confirm its status | Düsseldorf | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.